Opioid antagonists: do they have a role in treatment programs?
D002047:Buprenorphine / Q000627:therapeutic use; D004361:Drug Tolerance; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000517:prevention & control / Q000523:psychology / Q000534:rehabilitation*; D012008:Recurrence
D009292:Narcotic Antagonists; D002047:Buprenorphine; D009271:Naltrexone